EMA: Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU

This third public meeting will update to EU citizens about the continued assessment, approval and safety monitoring of COVID-19 vaccines, and their expected impact at community level.

It will cover:

  • COVID-19 vaccines approved in the EU and those currently under review;
  • post-authorisation activities, including emerging safety data since EU authorisation of the first COVID-19 vaccines;
  • ongoing work to address new variants;
  • the expected impact of COVID-19 vaccination on our society;
  • transparency and the publication of clinical data for COVID-19 vaccines.

The event will also allow the public and stakeholders to further inform EMA of their needs, expectations and any concerns.